SIM
PTCT icon

Spark Investment Management’s PTC Therapeutics PTCT Stock Holding History

Spark Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,500
Closed -$379K – 218
2020
Q1 		$379K Sell
8,500
-157,800
-95% -$7.94M 0.2% 159
2019
Q4 		$7.99M Sell
166,300
-29,800
-15% -$1.27M 0.94% 9
2019
Q3 		$6.63M Sell
196,100
-74,700
-28% -$3.25M 0.85% 19
2019
Q2 		$12.2M Sell
270,800
-295,200
-52% -$11.7M 0.84% 19
2019
Q1 		$21.3M Buy
566,000
+204,100
+56% +$6.85M 0.99% 19
2018
Q4 		$12.4M Buy
361,900
+111,900
+45% +$4.02M 0.86% 17
2018
Q3 		$11.8M Sell
250,000
-163,900
-40% -$6.78M 0.67% 22
2018
Q2 		$14M Sell
413,900
-241,600
-37% -$7.53M 0.82% 16
2018
Q1 		$17.7M Sell
655,500
-381,700
-37% -$9.67M 1.13% 6
2017
Q4 		$17.3M Buy
1,037,200
+320,200
+45% +$5.42M 0.93% 11
2017
Q3 		$14.3M Buy
717,000
+447,100
+166% +$8.75M 0.77% 13
2017
Q2 		$4.95M Buy
269,900
+226,300
+519% +$3.05M 0.31% 99
2017
Q1 		$429K Buy
+43,600
New +$528K 0.03% 564
2016
Q2 		– Sell
-274,100
Closed -$1.76M – 828
2016
Q1 		$1.76M Buy
274,100
+256,600
+1,466% +$4.45M 0.18% 187
2015
Q4 		$567K Buy
+17,500
New +$515K 0.07% 348
2014
Q2 		– Sell
-7,800
Closed -$203K – 713
2014
Q1 		$203K Buy
+7,800
New +$210K 0.03% 527
2013
Q4 		– Sell
-10,600
Closed -$226K – 691
2013
Q3 		$226K Buy
+10,600
New +$184K 0.05% 429

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Spark Investment Management's PTCT Position: Q2 2020 in Review

Spark Investment Management sold out of PTC Therapeutics (PTCT) in Q2 2020, closing a stake of 8,500 shares — an estimated $379K sold.

Spark Investment Management first reported a position in PTCT in Q3 2013 and held it in 17 quarters. The position peaked at $21.3M in Q1 2019. 203 funds tracked by Wall St. Rank hold PTCT as of Q2 2020.

  • Spark Investment Management reported no remaining PTC Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 8,500 PTC Therapeutics shares in Q2 2020, an estimated $379K.
  • Spark Investment Management first reported a position in PTC Therapeutics in Q3 2013 and held it in 17 quarters.
  • Spark Investment Management's PTC Therapeutics position peaked at $21.3M in Q1 2019.
  • 203 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.